Artemisinin-based combination therapy for ... - The Cochrane Library
Artemisinin-based combination therapy for ... - The Cochrane Library
Artemisinin-based combination therapy for ... - The Cochrane Library
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Analysis 6.2. Comparison 6 Artesunate plus mefloquine vs Artemether-lumefantrine, Outcome 2 Total<br />
Failure (P. falciparum) Day 42 PCR adjusted.<br />
Review: <strong>Artemisinin</strong>-<strong>based</strong> <strong>combination</strong> <strong>therapy</strong> <strong>for</strong> treating uncomplicated malaria<br />
Comparison: 6 Artesunate plus mefloquine vs Artemether-lumefantrine<br />
Outcome: 2 Total Failure (P. falciparum) Day 42 PCR adjusted<br />
1 Asia<br />
Study or subgroup AS+MQ AL6 Risk Ratio Weight Risk Ratio<br />
n/N n/N M-H,Random,95% CI M-H,Random,95% CI<br />
Hutagalung 2002 THA 9/212 3/201 34.7 % 2.84 [ 0.78, 10.36 ]<br />
Van den Broek 2003a BGD 0/105 3/102 21.7 % 0.14 [ 0.01, 2.65 ]<br />
Stohrer 2003 LAO 0/45 3/37 21.9 % 0.12 [ 0.01, 2.21 ]<br />
Mayxay 2003 LAO 0/106 3/96 21.7 % 0.13 [ 0.01, 2.48 ]<br />
0.005 0.1 1 10 200<br />
Favours ASMQ Favours AL<br />
Analysis 6.3. Comparison 6 Artesunate plus mefloquine vs Artemether-lumefantrine, Outcome 3 Total<br />
Failure (P. falciparum) Day 28 PCR unadjusted.<br />
Review: <strong>Artemisinin</strong>-<strong>based</strong> <strong>combination</strong> <strong>therapy</strong> <strong>for</strong> treating uncomplicated malaria<br />
Comparison: 6 Artesunate plus mefloquine vs Artemether-lumefantrine<br />
Outcome: 3 Total Failure (P. falciparum) Day 28 PCR unadjusted<br />
Study or subgroup AS+MQ AL6 Risk Ratio Weight Risk Ratio<br />
1 Africa<br />
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI<br />
Faye 2003 SEN 2/144 0/147 0.6 % 5.10 [ 0.25, 105.39 ]<br />
Sagara 2005b MLI 47/230 76/231 99.4 % 0.62 [ 0.45, 0.85 ]<br />
Subtotal (95% CI) 374 378 100.0 % 0.65 [ 0.48, 0.89 ]<br />
Total events: 49 (AS+MQ), 76 (AL6)<br />
Heterogeneity: Chi 2 = 1.86, df = 1 (P = 0.17); I 2 =46%<br />
Test <strong>for</strong> overall effect: Z = 2.72 (P = 0.0066)<br />
2 Asia<br />
Van Vugt 1998 THA 0/47 4/134 12.3 % 0.31 [ 0.02, 5.70 ]<br />
0.005 0.1 1 10 200<br />
Favours ASMQ Favours AL<br />
<strong>Artemisinin</strong>-<strong>based</strong> <strong>combination</strong> <strong>therapy</strong> <strong>for</strong> treating uncomplicated malaria (Review)<br />
Copyright © 2009 <strong>The</strong> <strong>Cochrane</strong> Collaboration. Published by John Wiley & Sons, Ltd.<br />
(Continued ...)<br />
156